Panel Discussion: Ophthalmic Gene Therapy Patient Perspective

Time: 4:05 pm
day: Day One


  • Do patients feel they know what treatments are available to them?
  • Is there trial data available to patients so they can decide if they want to participate?
  • How can an open line of communication be developed between patients and the industry?